Scientific Sessions 2025  /  Bad Blood: Swift(ie) Debates in Cardio-Oncology  /  PRO: You Need To Calm Down: We Are Imaging Too Often with HER2-Targeted Therapies!
Logo

American Heart Association

  24
  0

Final ID:

PRO: You Need To Calm Down: We Are Imaging Too Often with HER2-Targeted Therapies!

  • Nohria, Anju  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Decara, Jeanne  ( UNIVERSITY OF CHICAGO MEDICINE , Chicago , Illinois , United States )
    • Author Disclosures:
    Anju Nohria: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Bristol-Myers Squibb Company:Active (exists now) ; Consultant:Takeda Oncology:Past (completed) | Jeanne DeCara: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Royalties/Patent Beneficiary:Up to Date:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Bad Blood: Swift(ie) Debates in Cardio-Oncology

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
CON…Ready For It: Cardio-Oncology Board Certification is NOT Necessary To Practice Cardio-Oncology!

Gupta Dipti, Hayek Salim

PRO: I Can Do It With A Broken Heart: Permissive Cardiotoxicity Should Be Implemented in Anthracycline Cardiomyopathy!

Asnani Aarti, Porter Charles

More abstracts from these authors:
To Image vs Biopsy?- Managing Immune Checkpoint Inhibitor Myocarditis

Decara Jeanne, Gupta Dipti, Sarswat Nitasha

Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Con)

Nohria Anju, Asnani Aarti

You have to be authorized to contact abstract author. Please, Login
Not Available